Effects of Respiratory Muscle Training in Patients With Acute Ischemic Stroke

September 23, 2021 updated by: Chen ruey, Taipei Medical University Shuang Ho Hospital
After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.

Study Overview

Status

Recruiting

Conditions

Detailed Description

After acute ischemic stroke, the muscle strength of the limbs of the patients will decrease. Moreover, the respiratory muscles may also be affected. The worsening of the respiratory function is weakened and lung function declines, leading to dysfunction of expectoration and swallowing, and increasing the incidence of pneumonia after stroke. In addition, it will also lead to a decline in activity ability, which in turn affects the quality of life. The respiratory muscle training may improve the respiratory recovery and prevent pulmonary complication.

Study Type

Interventional

Enrollment (Anticipated)

144

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • New Taipei City, Taiwan, 235
        • Recruiting
        • Shuang Ho Hospital, Taipei Medical University
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Ischemic stroke diagnosed by MRI
  2. Age over 20 years old
  3. No worsening of stroke or second stroke this time

Exclusion Criteria:

  1. Unable to understand instructions normally, or communication difficulties
  2. Patients with endotracheal tube or tracheostomy
  3. Angina in recent 3 months, myocardial infarction, heart failure
  4. Patients with asthma or chronic obstructive pulmonary disease, spontaneous pneumothorax, and ongoing pneumonia
  5. Patients with untreated hernias
  6. Pregnant
  7. Ongoing fever (body temperature>38.5°C)
  8. Poor hypertension control (higher than 170/100 mmHg three days before intervention)
  9. Patients who have had cerebral hemorrhage or aneurysm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dofin Breathing Strength Builder
Usual post stroke care and respiratory muscle training

If the patient's condition is stable, respiratory muscle training will be performed under Dofin Breathing Strength Builder 7 days after stroke. The patient will receive respiratory muscle training by repetition of 30 times, two courses per day, x 7 days, for three weeks.

The initial load was set at 30% of the participants' maximal baseline strength and increased weekly at intervals of 2 cmH2O.

No Intervention: Usual post stroke care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Respiratory muscle function-1.1
Time Frame: Baseline
MEP (maximal expiratory pressure)
Baseline
Respiratory muscle function-1.2
Time Frame: Within one week after training
MEP (maximal expiratory pressure)
Within one week after training
Respiratory muscle function-1.3
Time Frame: Twelve weeks after training
MEP (maximal expiratory pressure)
Twelve weeks after training
Respiratory muscle function-2.1
Time Frame: Baseline
MIP (maximal inspiratory pressure)
Baseline
Respiratory muscle function-2.2
Time Frame: Within one week after training
MIP (maximal inspiratory pressure)
Within one week after training
Respiratory muscle function-2.3
Time Frame: Twelve weeks after training
MIP (maximal inspiratory pressure)
Twelve weeks after training

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dyspnea.1
Time Frame: Baseline
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Baseline
Dyspnea.2
Time Frame: Within one week after training
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Within one week after training
Dyspnea.3
Time Frame: Twelve weeks after training
Dyspnea assessed by Modified Borg Dyspnea Scale (MBS). MBS can go from 0-10, 10 is the more severe condition.
Twelve weeks after training
Exercise tolerance.1
Time Frame: Baseline
Exercise tolerance assessed by six-minute walk test (6MWT).
Baseline
Exercise tolerance.2
Time Frame: Within one week after training
Exercise tolerance assessed by six-minute walk test (6MWT).
Within one week after training
Exercise tolerance.3
Time Frame: Twelve weeks after training
Exercise tolerance assessed by six-minute walk test (6MWT).
Twelve weeks after training
Body composition.1
Time Frame: Baseline
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Baseline
Body composition.2
Time Frame: Within one week after training
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Within one week after training
Body composition.3
Time Frame: Twelve weeks after training
Body composition including body fat and muscle mass measured by multi frequency segmental body composition analyzer (TANITA).
Twelve weeks after training
Life quality.1
Time Frame: Baseline
Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Baseline
Life quality.2
Time Frame: Within one week after training
Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Within one week after training
Life quality.3
Time Frame: Twelve weeks after training
Quality of life assessed by Short-form 12 (SF-12). SF-12 can go from 0-100, 100 is the better life quality.
Twelve weeks after training
Swallowing.1
Time Frame: Baseline
Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Baseline
Swallowing.2
Time Frame: Within one week after training
Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Within one week after training
Swallowing.3
Time Frame: Twelve weeks after training
Swallowing function assessed by the Functional Oral Intake Scale (FOIS). The score can go from 1-7, 7 is the better oral intake condition.
Twelve weeks after training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 23, 2021

Primary Completion (Anticipated)

January 15, 2023

Study Completion (Anticipated)

July 15, 2023

Study Registration Dates

First Submitted

February 4, 2021

First Submitted That Met QC Criteria

June 24, 2021

First Posted (Actual)

July 2, 2021

Study Record Updates

Last Update Posted (Actual)

September 24, 2021

Last Update Submitted That Met QC Criteria

September 23, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke, Ischemic

Clinical Trials on Dofin Breathing Strength Builder

3
Subscribe